GMVD Stock Overview
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel.
G Medical Innovations Holdings Ltd Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.38|
|52 Week High||US$6.74|
|52 Week Low||US$0.32|
|1 Month Change||-59.50%|
|3 Month Change||-48.22%|
|1 Year Change||-85.54%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-69.76%|
Recent News & Updates
|GMVD||US Healthcare||US Market|
Return vs Industry: GMVD underperformed the US Healthcare industry which returned 14.3% over the past year.
Return vs Market: GMVD underperformed the US Market which returned -13.5% over the past year.
|GMVD Average Weekly Movement||36.4%|
|Healthcare Industry Average Movement||9.0%|
|Market Average Movement||7.9%|
|10% most volatile stocks in US Market||17.2%|
|10% least volatile stocks in US Market||3.2%|
Stable Share Price: GMVD is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 36% a week.
Volatility Over Time: GMVD's weekly volatility has increased from 23% to 36% over the past year.
About the Company
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company’s products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics.
G Medical Innovations Holdings Ltd Fundamentals Summary
|GMVD fundamental statistics|
Is GMVD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|GMVD income statement (TTM)|
|Cost of Revenue||US$3.56m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.61|
|Net Profit Margin||-291.78%|
How did GMVD perform over the long term?See historical performance and comparison